257 filings
Page 9 of 13
8-K
cjlk583y4 ys
7 Mar 18
Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
12:00am
8-K
hobvpi9wkn z0sitl06z
7 Mar 18
Entry into a Material Definitive Agreement
12:00am
CT ORDER
9crlsmzi2s6 pjw
1 Feb 18
Confidential treatment order
12:00am
8-K
pppg7 i1y5bc36nbst
8 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
fz52tqtki bzjsh2qe
18 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
prk 6kla4n
7 Nov 17
Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
12:00am
CT ORDER
id54mze
18 Sep 17
Confidential treatment order
12:00am
CT ORDER
dcxfq 0ab
5 Sep 17
Confidential treatment order
12:00am
8-K
mlf2xen4ljz8ow
3 Aug 17
Xenon Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
llcvm j5d
27 Jun 17
Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint
12:00am
8-K
uwn2 yb8z
2 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
wnhxox0
9 May 17
Xenon Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
iokhllt97yc6q0p
26 Apr 17
Xenon Expands Ion Channel Neurology Pipeline with Acquisition of New Potassium Channel Modulator for the Treatment of Epilepsy
12:00am
8-K
uaj60sk9
24 Mar 17
Other Events
12:00am
8-K
x430d11s9
14 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
2enm65e2of
9 Mar 17
Other Events
12:00am